Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference
Pulse Biosciences (Nasdaq: PLSE), specializing in Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, has announced its participation in the TD Cowen 45th Annual Health Care Conference in Boston. The company's management team will deliver a presentation on Wednesday, March 5, 2025, at 10:30 am ET.
Interested parties can access both live and recorded versions of the presentation through the company's investor website, specifically on the 'Events Calendar and Presentations' page at investors.pulsebiosciences.com.
Pulse Biosciences (Nasdaq: PLSE), specializzata nella tecnologia di Nanosecond Pulsed Field Ablation™ (nano-PFA o nsPFA™), ha annunciato la sua partecipazione alla 45ª Conferenza Annuale sulla Salute di TD Cowen a Boston. Il team di gestione dell'azienda terrà una presentazione mercoledì 5 marzo 2025, alle 10:30 ET.
Le parti interessate possono accedere sia alla versione live che a quella registrata della presentazione attraverso il sito web per investitori dell'azienda, specificamente nella pagina 'Calendario Eventi e Presentazioni' su investors.pulsebiosciences.com.
Pulse Biosciences (Nasdaq: PLSE), especializada en la tecnología de Ablación por Campo Pulsado de Nanosegundos™ (nano-PFA o nsPFA™), ha anunciado su participación en la 45ª Conferencia Anual de Atención Médica de TD Cowen en Boston. El equipo de gestión de la empresa ofrecerá una presentación el miércoles 5 de marzo de 2025, a las 10:30 am ET.
Las partes interesadas pueden acceder tanto a la versión en vivo como a la grabada de la presentación a través del sitio web para inversores de la empresa, específicamente en la página 'Calendario de Eventos y Presentaciones' en investors.pulsebiosciences.com.
펄스 바이오사이언스(Pulse Biosciences) (Nasdaq: PLSE)는 나노초 펄스 필드 절제(Nanosecond Pulsed Field Ablation™; nano-PFA 또는 nsPFA™) 기술을 전문으로 하며, TD Cowen 제45회 연례 헬스케어 컨퍼런스에 참석한다고 발표했습니다. 회사의 경영진은 2025년 3월 5일 수요일, 오전 10시 30분 ET에 발표를 진행할 예정입니다.
관심 있는 분들은 회사의 투자자 웹사이트를 통해 발표의 실시간 및 녹화된 버전을 모두 이용할 수 있으며, '이벤트 일정 및 발표' 페이지인 investors.pulsebiosciences.com에서 확인하실 수 있습니다.
Pulse Biosciences (Nasdaq: PLSE), spécialisée dans la technologie de l'Ablation par Champ Pulsé de Nanosecondes™ (nano-PFA ou nsPFA™), a annoncé sa participation à la 45ème Conférence Annuelle sur la Santé de TD Cowen à Boston. L'équipe de direction de l'entreprise présentera une communication le mercredi 5 mars 2025, à 10h30 ET.
Les parties intéressées peuvent accéder à la version en direct et à l'enregistrement de la présentation via le site web des investisseurs de l'entreprise, en particulier sur la page 'Calendrier des Événements et Présentations' à l'adresse investors.pulsebiosciences.com.
Pulse Biosciences (Nasdaq: PLSE), spezialisiert auf die Technologie der Nanoskalen Pulsfeld-Ablation™ (nano-PFA oder nsPFA™), hat seine Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen in Boston angekündigt. Das Management-Team des Unternehmens wird am Mittwoch, den 5. März 2025, um 10:30 Uhr ET eine Präsentation halten.
Interessierte Parteien können sowohl die Live- als auch die aufgezeichnete Version der Präsentation über die Investorenseite des Unternehmens abrufen, insbesondere auf der Seite 'Veranstaltungskalender und Präsentationen' unter investors.pulsebiosciences.com.
- None.
- None.
Pulse Biosciences’ Management is scheduled to present on Wednesday, March 5, 2025, at 10:30 am ET. A live and recorded webcast of the presentation will be available on the “Events Calendar and Presentations” page of the company’s investor website at http://investors.pulsebiosciences.com/.
About Pulse Biosciences®
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary CellFX® nsPFA™ technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers.
Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250220149557/en/
Investors:
Pulse Biosciences, Inc.
Jon Skinner, CFO
IR@pulsebiosciences.com
Or
Gilmartin Group
Philip Trip Taylor
415.937.5406
philip@gilmartinir.com
Source: Pulse Biosciences, Inc.
FAQ
When is Pulse Biosciences (PLSE) presenting at the TD Cowen Health Care Conference 2025?
How can investors watch Pulse Biosciences' (PLSE) TD Cowen conference presentation?
What technology will Pulse Biosciences (PLSE) discuss at the TD Cowen conference?
Where is the TD Cowen Healthcare Conference featuring Pulse Biosciences (PLSE) being held?
